Sumit Parikh, MD

Appointed
2004

Education & Fellowships

Fellowship - Cleveland Clinic
Neurometabolism & Genetics
Cleveland, OH
2006

Fellowship - Children's Hospital of Pittsburgh
Child Neurology
Pittsburgh, PA
2004

Residency - Children's Hospital of Pittsburgh
Pediatrics
Pittsburgh, PA
2001

Medical Education - Case Western Reserve University School of Medicine
MD
Cleveland, OH United States
1998

Undergraduate - Case Western Reserve University School of Medicine
Cleveland, OH
1994

Professional Highlights

• Past Editor, Mitochondrial & Metabolic Medicine
• Past-President, Mitochondrial Medicine Society
• Past-Chair, Scientific & Medical Advisory Board, United Mitochondrial Disease Foundation
• Primary Investigator, Mitochondrial Augmentation Therapy & Pearson Syndrome Natural History Study
• North American Mitochondrial Disease Consortium (NAMDC) member
• Global Leukodystrophy Initiative member and site director
• International Foundation for CDKL5 Research Center of Excellence
• Scientific & Medical Advisory Board, National Cyclic Vomiting Syndrome Association
• Scientific & Medical Advisory Board, International Foundation for CDKL5 Research
• Past Scientific Planning Committee, Child Neurology Society

Certifications

• Psychiatry and Neurology - Neurology with Special Qualifications in Child Neurology

Specialty Interests

The diagnosis and treatment of patients with mitochondrial cytopathies, inborn errors of metabolism, cognitive and developmental regression, leukodystrophies, autism and developmental delays

Awards & Honors

• Teacher/Lecturer of the Year, Cleveland Clinic Pediatric Residency, 2020
• Best Doctors in America, Castle-Connolly, 2007-present
• Top Scholar, Child Neurology Society Annual Meeting, October 2001
• Magna Cum Laude Graduate with Honors in English

Memberships

• American Academy of Neurology, fellow; certified in neurology, with special certification in child neurology
• American Academy of Pediatrics, fellow; certified in general pediatrics
• Child Neurology Society
• American College of Medical Genetics, affiliate specialist
• Society for Inherited Metabolic Disease
• Society for Study of Inborn Errors of Metabolism

See publications for Sumit Parikh, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/2/2024, Dr. Parikh has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Parikh receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Tisento Therapeutics, Inc. 

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.